Eye-Brain Connection: Encoding the Retina for Brain Health
Dr. Christy Sheehy-Bensinger, the Co-founder and CEO of C. Light Technologies, a neurotech and AI startup company whose mission is to develop digital solutions using eye motion metrics for potential prognostic and preventative care in neurology joins eHealth Radio and the Neurology and Technology Channels.
This episode of eHealth Radio is sponsored by C. Light Technologies. For more information visit clighttechnologies.com.
Listen to interview with host Eric Michaels and guest Dr. Christy Sheehy-Bensinger discuss the following:
Your research studies eye motion which could be a proxy to brain health and cognition. What is the significance of the connection between the eye and brain?
Why are doctors from all various fields so interested in what’s going on with people’s eyes today?
We’ve had transformative tech enter the medical field in the past few decades, but neurology seems to remain stuck in the past. What are the issues that neurology is facing today?
Based on your research, what changes in the medical field do you predict will happen and will help take fields like neurology into the 21st century?
For someone currently working in academia who says, “I have this great invention; I want to take it to market”: what advice would you give to someone planning to take that next step in embarking on that entrepreneurial journey?
Dr. Christy K. Sheehy-Bensinger, Ph.D. is the co-founder and CEO of C. Light Technologies – a neurotech and AI startup company whose mission is to develop digital solutions using eye motion metrics for potential prognostic and preventative care in neurology.
Dr. Sheehy-Bensigner has worked in the optical and ophthalmic engineering realm for more than 15 years with direct clinical research experience with neurodegenerative patient populations at top research institutions including University of California, Berkeley and University of California, San Francisco.
Dr. Sheehy-Bensigner is a published scientific author and has given invited presentations domestically and internationally on the subjects of neuro-optometry, engineering, and design. She has been awarded three NIH Small Business grants and an investment from the Alzheimer’ Drug Discovery Foundation (ADDF). She has brought in over $7M in funding via grants, angel & venture capital investments to date.